StonvexLoading…
StonvexStonvexStonvexCore line items from ACFN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $11.48M | $10.99M | $8.06M | $7.00M |
Operating Income | $1.99M | $1.94M | $74.00K | $-629.00K |
Net Income | $2.51M | $6.29M | $119.00K | $-633.00K |
EPS (Diluted) | $0.99 | $2.51 | $0.05 | $-0.25 |
Total Assets | $13.33M | $10.60M | $5.45M | $5.98M |
Total Liabilities | $5.02M | $5.02M | $6.28M | $7.00M |
Cash & Equivalents | $4.45M | $2.33M | $1.45M | $1.45M |
Free Cash Flow OCF − CapEx | $2.08M | $897.00K | $70.00K | Not available |
Shares Outstanding | 2.50M | 2.49M | 2.48M | 2.48M |